BCAL Diagnostics (ASX:BDX) Pretax Margin % : % (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BCAL Diagnostics's Pre-Tax Income for the six months ended in Dec. 2023 was A$-2.41 Mil. BCAL Diagnostics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, BCAL Diagnostics's pretax margin for the quarter that ended in Dec. 2023 was %.

The historical rank and industry rank for BCAL Diagnostics's Pretax Margin % or its related term are showing as below:

ASX:BDX's Pretax Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -13.24
* Ranked among companies with meaningful Pretax Margin % only.

BCAL Diagnostics Pretax Margin % Historical Data

The historical data trend for BCAL Diagnostics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Pretax Margin % Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Pretax Margin %

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Pretax Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of BCAL Diagnostics's Pretax Margin %

For the Diagnostics & Research subindustry, BCAL Diagnostics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Pretax Margin % falls into.

BCAL Diagnostics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

BCAL Diagnostics's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-5.062	/	0
	=	%

BCAL Diagnostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2.407	/	0
	=	%

BCAL Diagnostics (ASX:BDX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

BCAL Diagnostics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.